Sarah Hogan represents companies in the life sciences and digital health industries on structuring and negotiating intellectual property licenses, strategic collaborations and other complex commercial transactions – helping her clients leverage intellectual property assets and collaborate to develop and deliver innovative solutions that improve health and health care. Sarah uses her science background and comprehensive life sciences industry knowledge as an asset to understand critical business concerns and effectively manage complex issues. As a result of the diverse range of clients and transactions she manages, Sarah has in-depth understanding of the implications of each deal on various aspects of the business, including downstream transactions. Sarah is known for her practical approach – focusing on achieving business objectives while balancing legal risks and preserving her clients’ relationship with their partners.
Sarah regularly advises clients on the following transactions: license and collaboration transactions to develop and commercialize pharmaceutical and medical device products; cross-industry collaborations, joint development arrangements and joint ventures for products in the convergence of health, technology and life sciences; licensing patents, software and other technology from universities; licensing data products and data analytics solutions involving health information; licensing health IT products for both on premise and hosted (including cloud-based) solutions, including hosting, support and maintenance agreements; and manufacturing, supply and distribution agreements relating to pharmaceutical products at all stages of the product life cycle. She represents numerous types of clients, including start-up companies, venture capital and private equity-backed entities, large public companies, privately held businesses, hospitals and nonprofit research institutions.